Are low-serum testosterone levels pre-liver transplantation associated with reduced rates of early acute allograft rejection in men?
Low preliver transplant serum testosterone independently predicts a decreased risk of acute allograft rejection. Whether testosterone is a marker of disease-associated immune dysfunction or has immune-modulatory effects requires further study.
STAT1 and STAT2 are involved in the growth inhibition of human hepatoma HepG2 cells induced by PE.